Surgepays Vs. Rhythm Pharmaceuticals Industry Stock Comparison

Sell

28

SURG
Surgepays

Last Price:

1.72

Seasonality Move:

35.46%

Buy

73

RYTM
Rhythm Pharmaceuticals

Last Price:

54.42

Seasonality Move:

11.04%

Sell

28

Surgepays (SURG) is a Sell

Is Surgepays a Buy, Sell or Hold?

The current Surgepays [SURG] share price is $1.66. The Score for SURG is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
SURG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Buy

73

Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

The current Rhythm Pharmaceuticals [RYTM] share price is $53.65. The Score for RYTM is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
RYTM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SURG Stock Price Chart

What is Surgepays's stock price today?

The Surgepays share price today is $1.66
The current trend is relatively stagnant and SURG is experiencing slight selling pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

The Rhythm Pharmaceuticals share price today is $53.65
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

SURG Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.19	Sell
Relative Strength Index (14 RSI):	42.1	Sell
Chaikin Money Flow:	-21831	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.48 - 1.9)	Sell
Bollinger Bands (100):	(2.1 - 3.84)	Sell

RYTM Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	1.46	Buy
Relative Strength Index (14 RSI):	67.83	Buy
Chaikin Money Flow:	-159819	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(45.64 - 50.28)	Buy
Bollinger Bands (100):	(39.46 - 48.56)	Buy

SURG Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.55	Buy
20-day SMA:	1.62	Buy
50-day SMA:	2.27	Sell
200-day SMA:	4.45	Sell
8-day EMA:	1.59	Buy
20-day EMA:	1.7	Sell
50-day EMA:	2.19	Sell
200-day EMA:	3.77	Sell

RYTM Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	50.55	Buy
20-day SMA:	48.38	Buy
50-day SMA:	47.86	Buy
200-day SMA:	43.39	Buy
8-day EMA:	50.8	Buy
20-day EMA:	49.06	Buy
50-day EMA:	47.17	Buy
200-day EMA:	41.51	Buy

Surgepays Earnings Growth & SURG Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.57 per share, an increase next quarter of $0.26 per share, a decrease this year of $2.46 per share, and an increase next year of $0.73 per share.

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.11 per share, a decrease this year of $1.34 per share, and an increase next year of $1.63 per share.

Surgepays Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals Technical Analysis

	Sep 5	Sep 6	Sep 9	Sep 10	Sep 11	Sep 12	Sep 13	Sep 16	Sep 17	Sep 18
	Sep
	05	06	09	10	11	12	13	16	17	18
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):